[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:arrhythmic-cardiomyopathy":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":42,"states":46},"Arrhythmic cardiomyopathy",5,4,[8,16,23,29,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05885412","A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)",[12],"Phase 1","RECRUITING","2026-08-26T02:17:39.857430Z","2026-05-05T02:43:29.662378Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07159074","Repurposing Tilmanocept for Cardiac Sarcoidosis",[20],"Phase 2","2026-08-26T02:17:26.640202Z","2026-05-05T02:43:27.855769Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06976606","A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM",[],"2026-08-26T02:18:32.765187Z","2026-05-13T02:55:06.603699Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06644742","PKP2-ACM Natural History Study",[],"2026-08-26T02:17:19.710918Z","2026-05-13T02:55:06.559766Z",{"nct_id":36,"title":37,"phases":38,"status":39,"updated_at":40,"content_modified":41},"NCT07050160","Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:54.044282Z","2026-06-16T05:54:07.850330Z",[43],{"biomarker":44,"count":6,"slug":45},"PKP2 Gene","pkp2-gene",[47],{"state":48,"count":49,"slug":50},"North Carolina",3,"north-carolina"]